Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A <i>CACNB2b</i> variant causing reduced Ca<sub>V</sub>1.2 current in monozygotic twin brothers with Brugada syndrome.

HeartRhythm case reports·2026
Same author

Effect of magnetic field strength and segmentation variability on the reproducibility and repeatability of radiomic texture features in cardiovascular magnetic resonance parametric mapping.

The international journal of cardiovascular imaging·2025
Same author

Identification and characterization of two novel KCNH2 mutations contributing to long QT syndrome.

PloS one·2024
Same author

TIME- AND FREQUENCY-BASED INDEPENDENT EVALUATION OF QRST CANCELLATION TECHNIQUES FOR SINGLE-LEAD ELECTROCARDIOGRAMS DURING ATRIAL FIBRILLATION.

Annual Modeling and Simulation Conference (ANNSIM). Annual Modeling and Simulation Conference (Online)·2023
Same author

Optical Deformation of Biological Cells using Dual-Beam Laser Tweezer.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2022
Same author

The G213D variant in Nav1.5 alters sodium current and causes an arrhythmogenic phenotype resulting in a multifocal ectopic Purkinje-related premature contraction phenotype in human-induced pluripotent stem cell-derived cardiomyocytes.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2022

Related Experiment Video

Updated: Oct 30, 2025

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

13.7K

An in silico hiPSC-Derived Cardiomyocyte Model Built With Genetic Algorithm.

Akwasi D Akwaboah1, Bright Tsevi1, Pascal Yamlome1

  • 1Department of Engineering, Norfolk State University, Norfolk, VA, United States.

Frontiers in Physiology
|July 5, 2021
PubMed
Summary

This study introduces a novel genetic algorithm (GA) protocol for creating accurate biophysical models of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). The developed model effectively reproduces key electrophysiological parameters, validating hiPSC-CMs for cardiac research.

Keywords:
biophysical modelcardiac electrophysiologycomputational biologygenetic algorithmhiPSC-derived cardiomyocytes

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.9K
Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
09:23

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Published on: March 10, 2023

4.4K

Related Experiment Videos

Last Updated: Oct 30, 2025

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

13.7K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.9K
Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
09:23

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Published on: March 10, 2023

4.4K

Area of Science:

  • Computational Biology
  • Biophysics
  • Cardiovascular Research

Background:

  • Accurate in silico biophysical models are essential for understanding cellular electrophysiology.
  • Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are increasingly used in cardiac safety pharmacology and disease modeling.
  • Developing high-fidelity models for hiPSC-CMs requires robust optimization strategies.

Purpose of the Study:

  • To demonstrate the effectiveness of heuristic techniques, specifically a novel genetic algorithm (GA) protocol, for formulating biophysical models.
  • To develop a computational biophysical model of hiPSC-CMs using the proposed GA protocol.
  • To validate the accuracy of the developed hiPSC-CM model by comparing its output with experimental data.

Main Methods:

  • A novel genetic algorithm (GA) protocol was developed and applied to fit mathematical formulations to experimental data for five ionic currents in hiPSC-CMs.
  • Maximum conductances of other ionic channels were scaled using literature recommendations.
  • The GA protocol was used to optimize parameters for a hiPSC-CM biophysical model.

Main Results:

  • Near-optimal parameter fitting was achieved for the GA-fitted ionic currents.
  • The resulting hiPSC-CM model accurately recapitulated experimental action potential (AP) parameters, including AP durations (APD50, APD75, APD90), maximum diastolic potential, and automaticity frequency.
  • The model demonstrated the potential of heuristic techniques in biophysical model formulation.

Conclusions:

  • The study presents a novel GA protocol for formulating robust numerical biophysical models.
  • The developed hiPSC-CM model validates the biophysics of these cells as substitutes for human cardiomyocytes.
  • The findings have significant implications for cardiac safety pharmacology and the study of inherited cardiac disorders.